Immunochemotherapy, Zevalin, and Bone Marrow Transplant for Follicular Lymphoma (MasterPlan)
This study is currently recruiting participants.
Verified May 2010 by St. Louis University
Sponsor:
St. Louis University
Information provided by:
St. Louis University
ClinicalTrials.gov Identifier:
NCT01130194
First received: May 24, 2010
Last updated: July 19, 2011
Last verified: May 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | July 2026 |
| Estimated Primary Completion Date: | August 2016 (Final data collection date for primary outcome measure) |
Publications:
Fesler MJ, Osman M, Glauber J, Petruska PJ. C-MOPP: Results of a Forgotten Regimen in the Era of Rituximab and PET. Blood (ASH Annual Meeting Abstracts 2009) #4577.